The Office of Inspector General (OIG) issued its first in a series of examinations of drug supply chain security that will outline provisions for the implementation of the Drug Supply Chain Security Act (DSCSA). This report discusses:
-The OIG's methodology
-Key findings from the report
-Recommendations based on the FDA and OIG's findings
Sign-up now to instantly view the document.